Event JSON
{
"id": "45256c9b1ad073c7c891a84149ec03973eedd6288acc94433706462df07171ff",
"pubkey": "261776f4b97d13687d2213896785134f9a251d249618a68586a9b85a117b1377",
"created_at": 1694787856,
"kind": 1,
"tags": [
[
"t",
"Tech"
],
[
"t",
"arstechnica"
],
[
"t",
"it"
],
[
"t",
"technology"
],
[
"t",
"advisorycommittee"
],
[
"t",
"over"
],
[
"t",
"allergymedicine"
],
[
"t",
"phenylephrine"
],
[
"t",
"coldmedicine"
],
[
"t",
"drugefficacy"
],
[
"t",
"efficacy"
],
[
"t",
"mucinex"
],
[
"t",
"sudafed"
],
[
"t",
"health"
],
[
"t",
"nyquil"
],
[
"t",
"Merck"
],
[
"t",
"chpa"
],
[
"t",
"fda"
],
[
"proxy",
"https://mastodon.roitsystems.ca/users/TechNews/statuses/111069616943031013",
"activitypub"
]
],
"content": "Ars Technica: The spectacular downfall of a common, useless cold medicine https://arstechnica.com/?p=1968612 #Tech #arstechnica #IT #Technology #advisorycommittee #over-the-counter #allergymedicine #phenylephrine #coldmedicine #drugefficacy #efficacy #mucinex #sudafed #Health #nyquil #merck #CHPA #fda",
"sig": "a45f607b501270eb6234311ef6bc317bc5c0aa20a9ccca411e61583d9ebfb4dda80bed0f98723683a0d280bef907ee2e00324097b6a83dd04aff34d79395608c"
}
